131 related articles for article (PubMed ID: 8951197)
1. A single sample saliva test to determine acetylator phenotype.
Hutchings AD; Routledge PA
Br J Clin Pharmacol; 1996 Nov; 42(5):635-7. PubMed ID: 8951197
[TBL] [Abstract][Full Text] [Related]
2. Isoniazid Acetylation Phenotyping in the Japanese: The Molar Metabolic Ratio INH/AcINH.
Kohno H; Kubo H; Takada A; Mori M; Arias TD
Am J Ther; 1996 Jan; 3(1):74-78. PubMed ID: 11856999
[TBL] [Abstract][Full Text] [Related]
3. Saliva and plasma concentrations of isoniazid and acetylisoniazid in man.
Hutchings AD; Monie RD; Spragg BP; Routledge PA
Br J Clin Pharmacol; 1988 May; 25(5):585-9. PubMed ID: 3408638
[TBL] [Abstract][Full Text] [Related]
4. A simple method for determining acetylator phenotype using isoniazid.
Hutchings A; Routledge PA
Br J Clin Pharmacol; 1986 Sep; 22(3):343-5. PubMed ID: 3768246
[TBL] [Abstract][Full Text] [Related]
5. Isoniazid disposition, comparison of isoniazid phenotyping methods in and acetylator distribution of Japanese patients with idiopathic systemic lupus erythematosus and control subjects.
Horai Y; Ishizaki T; Sasaki T; Koya G; Matsuyama K; Iguchi S
Br J Clin Pharmacol; 1982 Mar; 13(3):361-74. PubMed ID: 7059436
[TBL] [Abstract][Full Text] [Related]
6. Isoniazid acetylation phenotyping in Saudi Arabs.
Matar KM; Mayet AY; Ayoola EA; Bawazir SA; Al-Faleh FZ; Al-Wazzan A
J Clin Pharm Ther; 2004 Oct; 29(5):443-7. PubMed ID: 15482388
[TBL] [Abstract][Full Text] [Related]
7. Determination of isoniazid half-life from salivary samples.
Suryawati S; Santoso B
Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):18-22. PubMed ID: 3957485
[TBL] [Abstract][Full Text] [Related]
8. Acetylator phenotyping: a comparison of the isoniazid and dapsone tests.
Hanson A; Melander A; Wåhlin-Boll E
Eur J Clin Pharmacol; 1981; 20(3):233-4. PubMed ID: 7286042
[TBL] [Abstract][Full Text] [Related]
9. Genetically determined variability in acetylation and oxidation. Therapeutic implications.
Clark DW
Drugs; 1985 Apr; 29(4):342-75. PubMed ID: 2859977
[TBL] [Abstract][Full Text] [Related]
10. N-Acetyltransferase2 genotype correlated with isoniazid acetylation in Japanese tuberculous patients.
Kita T; Tanigawara Y; Chikazawa S; Hatanaka H; Sakaeda T; Komada F; Iwakawa S; Okumura K
Biol Pharm Bull; 2001 May; 24(5):544-9. PubMed ID: 11379777
[TBL] [Abstract][Full Text] [Related]
11. Determination of the acetylator phenotype in Moroccan tuberculosis patients using isoniazid as metabolic probe.
Aït Moussa L; Khassouani CE; Hüe B; Jana M; Bégaud B; Soulaymani R
Int J Clin Pharmacol Ther; 2002 Dec; 40(12):548-53. PubMed ID: 12503812
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetic analysis of isoniazid, acetylisoniazid, and isonicotinic acid in healthy volunteers.
Seng KY; Hee KH; Soon GH; Chew N; Khoo SH; Lee LS
Antimicrob Agents Chemother; 2015 Nov; 59(11):6791-9. PubMed ID: 26282412
[TBL] [Abstract][Full Text] [Related]
13. Effect of coadministration of procainamide and isoniazid on each other's acetylation pathway.
Schneck DW; Sprouse JS; Shiroff RA; Vary JE; DeWitt FO; Hayes AH
Pharmacology; 1979; 18(1):34-41. PubMed ID: 419159
[TBL] [Abstract][Full Text] [Related]
14. The effects of acute ethanol intake on isoniazid pharmacokinetics.
Dattani RG; Harry F; Hutchings AD; Routledge PA
Eur J Clin Pharmacol; 2004 Nov; 60(9):679-82. PubMed ID: 15568141
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic interaction of simultaneously administered isoniazid and phenytoin in patients with tuberculous meningitis or tuberculoma having seizures.
Adole PS; Singh A; Kharbanda PS; Sharma S
Eur J Pharmacol; 2013 Aug; 714(1-3):157-62. PubMed ID: 23792142
[TBL] [Abstract][Full Text] [Related]
16. Population Pharmacokinetics and Pharmacodynamics of Isoniazid and its Metabolite Acetylisoniazid in Chinese Population.
Chen B; Shi HQ; Feng MR; Wang XH; Cao XM; Cai WM
Front Pharmacol; 2022; 13():932686. PubMed ID: 35928262
[No Abstract] [Full Text] [Related]
17. Isoniazid pharmacokinetics in children according to acetylator phenotype.
Rey E; Gendrel D; Treluyer JM; Tran A; Pariente-Khayat A; d'Athis P; Pons G
Fundam Clin Pharmacol; 2001 Oct; 15(5):355-9. PubMed ID: 11903505
[TBL] [Abstract][Full Text] [Related]
18. Effect of concomitant isoniazid administration on determination of acetylator phenotype by sulphadimidine.
Zysset T; Peretti E
Eur J Clin Pharmacol; 1986; 30(4):463-6. PubMed ID: 3743623
[TBL] [Abstract][Full Text] [Related]
19. Acetylator phenotype and metabolic disposition of isoniazid in Japanese patients with systemic lupus erythematosus.
Ishizaki T; Horai Y; Koya G; Matsuyama K; Iguchi S
Arthritis Rheum; 1981 Oct; 24(10):1245-54. PubMed ID: 7306226
[TBL] [Abstract][Full Text] [Related]
20. Acetylator phenotyping of tuberculosis patients using matrix isoniazid or sulphadimidine and its prognostic significance for treatment with several intermittent isoniazid-containing regimens.
Ellard GA; Gammon PT
Br J Clin Pharmacol; 1977 Feb; 4(1):5-14. PubMed ID: 843424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
